Cancer Institute and Hospital,Chinese Academy of Medical Sciences — Beijing

Public research footprint of Cancer Institute and Hospital,Chinese Academy of Medical Sciences, compiled from the ClinicalTrials.gov public registry.

165

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Solid Tumor · Advanced Breast Cancer · Nasopharyngeal Carcinoma (NPC)

Recently updated registry entries

NCT02486718 — Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best… (Active Not Recruiting)
NCT06038461 — An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1… (Recruiting)
NCT07681323 — Timing of ctDNA Testing in Advanced Breast Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cancer Institute and Hospital,Chinese Academy of Medical Sciences?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.